Shannon Schwartz
Women's Health · Topeka, KSNPI 1053608661
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $523 of the $623 with a category attached, or 84.0%. It is spread thinly across 12 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $424 and has fallen 96.8% since, to $13 in 2024.
Across 29 payments — averaging $21.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$128
- AbbVie$93
- Agile Therapeutics, Inc.$84
- Organon$63
- Exeltis, USA Inc.$50
- Axonics, Inc.$50
- plus $156 from 6 others
What the payments were for
- Food & beverage$52384%
- Education$10016%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 3 | $128 |
| AbbVie | 5 | $93 |
| Agile Therapeutics, Inc. | 4 | $84 |
| Organon | 3 | $63 |
| Exeltis, USA Inc. | 3 | $50 |
| Axonics, Inc. | 3 | $50 |
| Medtronic | 1 | $42 |
| Bayer | 2 | $35 |
| Therapeuticsmd, Inc. | 2 | $27 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Evofem Biosciences, Inc. | 1 | $14 |
How this compares
$623 in reported general payments places this provider in the 70th percentile of 43 women's health providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 21 | $842 |
| ProgesteroneProgesterone, Micronized | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other women's health in Topeka
- Cindy CondrayTopeka$858
- Patricia SmithTopeka$101
- Stacy CorumMerriam$4K
- Marcia SnodgrassDodge City$3K
- Julie BiermannOverland Park$3K
- Jennifer PeppardMerriam$2K
- Brandi MulryanOverland Park$2K
- Patricia ArnoldMerriam$2K
- Diane WendelkenManhattan$2K
- Jessica FergasonOverland Park$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.